US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5

US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5

4.5
(376)
Write Review
More
$ 15.00
Add to Cart
In stock
Description

The in vivo antitumor activity of CD5-targeting CAR-T cells in the

CD5 Mouse anti-Chicken, Biotin, Clone: 2-191, Southern Biotech

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

Targeting cardiac fibrosis with engineered T cells

Frontiers Nanotechnology in Drug Delivery for Liver Fibrosis

WO2015183842A1 - Methods and compositions for preventing ischemia

CD352 (NTB-A) Antibody, anti-human, REAfinity™

In vivo imaging of prostate cancer using an anti-PSMA scFv

CD45RA Antibody, anti-human, REAfinity™

CD45 Antibody (MEM-28) - BSA Free (NB500-319): Novus Biologicals

In vivo production of CAR-T cells using CD5/LNP-FAPCAR